{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T10:12:34Z","timestamp":1767953554165,"version":"3.49.0"},"reference-count":21,"publisher":"Termedia Sp. z.o.o.","issue":"2","license":[{"start":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T00:00:00Z","timestamp":1595808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"},{"start":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T00:00:00Z","timestamp":1595808000000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"},{"start":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T00:00:00Z","timestamp":1595808000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cent Eur J Immunol"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Bacillus Calmette-Gu\u00e9rin (BCG) is the only tuberculosis vaccine available and although it has been routinely used for more than 80 years, its protective effect varies depending on the age and the form of tuberculosis. Due to the close analogy between the vaccine strain and other species of the Mycobacterium tuberculosis complex, molecular methods are recommended for differential diagnosis of post-BCG complications. The aim of the study was to assess usefulness of molecular methods in diagnosis of post-BCG vaccine adverse events (VAEs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and methods<\/jats:title>\n                    <jats:p>M. tuberculosis complex strains obtained in 2011-2017 from 68 ill children were subjected to molecular analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Molecular analysis of 68 strains showed 100% agreement between the results in the GenoType MTBC method and the multiplex PCR method. For the strains isolated from 45 patients with suspected VAE, M. bovis BCG was obtained, whereas the strains isolated from the remaining 23 children were identified as M. tuberculosis. The analysis confirmed the close relationship between the result of identification and the type of material as well as the patient\u2019s age.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The use of genetic methods enables quick and detailed diagnostics of infections caused by M. bovis BCG, which allows for the confirmation or exclusion of VAE.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5114\/ceji.2020.97900","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T03:48:20Z","timestamp":1598413700000},"page":"130-135","source":"Crossref","is-referenced-by-count":1,"title":["Molecular methods in diagnostics of post-BCG vaccine adverse events"],"prefix":"10.5114","volume":"45","author":[{"given":"Sylwia Agata","family":"Brzezi\u0144ska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Bielecka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Zabost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"G\u0142ogowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Kozi\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Augustynowicz-Kope\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3061","published-online":{"date-parts":[[2020,7,27]]},"reference":[{"key":"ref-1545701","author":"World Health Organization","year":"2018","unstructured":"World Health Organization (2018): Global tuberculosis report 2018. Geneva."},{"key":"ref-1545702","first-page":"B5304","article-title":"Bacillus Calmette-Gu\u00e9rin vaccination at birth:Effects on early childhood infections, growth, and development","volume":"63","author":"Kjaergaard J","year":"2016","unstructured":"Kjaergaard J (2016): Bacillus Calmette-Gu\u00e9rin vaccination at birth:Effects on early childhood infections, growth, and development. Dan Med J 63: B5304.","journal-title":"Dan Med J"},{"key":"ref-1545703","first-page":"2675","article-title":"Report on a WHO consultation on the characterisation of BCG strains","volume":"22","author":"Corbel MJ","year":"2004","unstructured":"Corbel MJ, Fruth U, Griffiths EI, et al. (2004): Report on a WHO consultation on the characterisation of BCG strains. Imperial College, London 15-16 December 2003.Vaccine 22: 2675-2680.","journal-title":"Imperial College, London 15-16 December 2003.Vaccine"},{"key":"ref-1545704","volume-title":"Instytut Gru\u017alicy i Chor\u00f3b P\u0142uc, Warszawa","author":"Korzeniewska-Kose\u0142a M (ed.)","year":"2017","unstructured":"Korzeniewska-Kose\u0142a M (ed.) (2017): Gru\u017alica i choroby uk\u0142adu oddechowego w Polsce w 2016 roku. Instytut Gru\u017alicy i Chor\u00f3b P\u0142uc, Warszawa."},{"key":"ref-1545705","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0962-8479(94)90003-5","article-title":"Criteria for discontinuation of vaccination programmes using Bacille Calmette-Guerin (BCG) in countries with a low prevalence of tuberculosis. A statement of the International Union Against Tuberculosis and Lung Disease","volume":"75","author":"[No authors listed]","year":"1994","unstructured":"[No authors listed] (1994): Criteria for discontinuation of vaccination programmes using Bacille Calmette-Guerin (BCG) in countries with a low prevalence of tuberculosis. A statement of the International Union Against Tuberculosis and Lung Disease. Tuber Lung Dis 75: 179-180.","journal-title":"Tuber Lung Dis"},{"key":"ref-1545706","first-page":"221","article-title":"Risk of BCG infection in primary immunodeficiency children. Proposal of diagnostics, prophylactic and therapeutic guidelines for disseminated BCG based on experience In the Department of Immunology, Childrens Memorial Health Institute In Warsaw between 1980-2006","volume":"32","author":"Bernatowska E","year":"2007","unstructured":"Bernatowska E, Wolska-Ku\u015bnierz B, Pac M, et al. (2007): Risk of BCG infection in primary immunodeficiency children. Proposal of diagnostics, prophylactic and therapeutic guidelines for disseminated BCG based on experience In the Department of Immunology, Childrens Memorial Health Institute In Warsaw between 1980-2006. Centr Eur J Immunol 32: 221-225.","journal-title":"Centr Eur J Immunol"},{"key":"ref-1545707","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3348\/kjr.2000.1.2.114","article-title":"Disseminated BCG infection in a patient with severe combined immunodeficiency","volume":"1","author":"Han TII","year":"2000","unstructured":"Han TII, Kim I-O, Kim WS, et al. (2000): Disseminated BCG infection in a patient with severe combined immunodeficiency. Korean J Radiol 1: 114-117.","journal-title":"Korean J Radiol"},{"key":"ref-1545708","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5603\/ARM.2018.0023","article-title":"Recommendations for the management of tuberculosis in children.KOMPASS TB. Part 1: Tuberculosis prevention","volume":"86","author":"Bielecka T","year":"2018","unstructured":"Bielecka T, Augustynowicz-Kope\u0107 E, Gonerko P, et al. (2018): Recommendations for the management of tuberculosis in children.KOMPASS TB. Part 1: Tuberculosis prevention. Adv Respir Med 86: 149-157.","journal-title":"Adv Respir Med"},{"key":"ref-1545709","first-page":"1259","article-title":"Microevolution of BCG substrains","volume":"70","author":"Krysztopa-Grzybowska K","year":"2016","unstructured":"Krysztopa-Grzybowska K, Luty\u0144ska A (2016): Microevolution of BCG substrains. Postepy Hig Med Dosw 70: 1259-1266.","journal-title":"Postepy Hig Med Dosw"},{"key":"ref-1545710","first-page":"62","article-title":"Rozpoznawanie i leczenie niepo\u017c\u0105danych odczyn\u00f3w po szczepieniu BCG","volume":"2","author":"Komorowska-Piotrowska A","year":"2015","unstructured":"Komorowska-Piotrowska A, Bielecka T, Feleszko W (2015): Rozpoznawanie i leczenie niepo\u017c\u0105danych odczyn\u00f3w po szczepieniu BCG. Terapia 2: 62-65.","journal-title":"Terapia"},{"key":"ref-1545711","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.arcped.2016.04.003","article-title":"BCGitis\/BCGosis in children: Diagnosis, classification and exploration","volume":"23","author":"Kourime M","year":"2016","unstructured":"Kourime M, Akpalu ENK, Ouair H, et al. (2016): BCGitis\/BCGosis in children: Diagnosis, classification and exploration. Arch Pediatr 23: 754-759.","journal-title":"Arch Pediatr"},{"key":"ref-1545712","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1128\/jcm.35.3.566-569.1997","article-title":"PCR identification of Mycobacterium bovis BCG","volume":"35","author":"Talbot EA","year":"1997","unstructured":"Talbot EA, Wiliams DL, Frothingham R (1997): PCR identification of Mycobacterium bovis BCG. J. Clin Microbiol 35: 566-569.","journal-title":"J. Clin Microbiol"},{"key":"ref-1545713","first-page":"1","article-title":"Tuberculosis","author":"Dheda K","year":"6736","unstructured":"Dheda K, Barry CE, Martens G (2015): Tuberculosis. Lancet 6736: 1-17.","journal-title":"Lancet"},{"key":"ref-1545714","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5588\/ijtld.17.0842","article-title":"Mission impossible: the End TB strategy","volume":"22","author":"Dudnyk A","year":"2018","unstructured":"Dudnyk A, Chesov D, Lange Ch (2018): Mission impossible: the End TB strategy. Int J Tuberc Lung Dis 22: 121-122.","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref-1545715","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00281-017-0654-9","article-title":"Vaccine responses in newborns","volume":"39","author":"Saso A","year":"2017","unstructured":"Saso A, Kampmann B (2017): Vaccine responses in newborns. Semin Immunopathol 39: 627-642.","journal-title":"Semin Immunopathol"},{"key":"ref-1545716","first-page":"617","article-title":"Experience de vaccination par le BCG dans la provine du norbotten","volume":"12","author":"Naeslund C","year":"1931","unstructured":"Naeslund C (1931): Experience de vaccination par le BCG dans la provine du norbotten. Rev Tuberc 12: 617-636.","journal-title":"Rev Tuberc"},{"key":"ref-1545717","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/bmj.2.6082.293","article-title":"BCG and vole Bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life","volume":"2","author":"Hart PD","year":"1977","unstructured":"Hart PD, Sutherland I (1977): BCG and vole Bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Br Med J 2: 293-295.","journal-title":"Br Med J"},{"key":"ref-1545718","first-page":"B5304","article-title":"Bacillus Calmette-Gu\u00e9rin vaccination at birth: Effects on early childhood infections, growth, and development","volume":"63","author":"Kjaergaard J","year":"2016","unstructured":"Kjaergaard J (2016): Bacillus Calmette-Gu\u00e9rin vaccination at birth: Effects on early childhood infections, growth, and development. Dan Med J 63: B5304.","journal-title":"Dan Med J"},{"key":"ref-1545719","first-page":"1528981","article-title":"Successful Treatment of Disseminated Bacillus Calmette-Gu\u00e9rin Disease in an HIV-Infected Child with a linezolid-containing regimen","author":"Rogli\u0107 S","year":"2016","unstructured":"Rogli\u0107 S, Dickson D, Mi\u0161e B, et al. (2016): Successful Treatment of Disseminated Bacillus Calmette-Gu\u00e9rin Disease in an HIV-Infected Child with a linezolid-containing regimen. Case Rep Infect Dis 2016: 1528981.","journal-title":"Case Rep Infect Dis"},{"key":"ref-1545720","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000247372","article-title":"BCG-vaccine-induced lupus vulgaris and urticarial vasculitis","volume":"186","author":"Misery L","year":"1993","unstructured":"Misery L, Combemale P (1993): BCG-vaccine-induced lupus vulgaris and urticarial vasculitis. Dermatology 186: 274.","journal-title":"Dermatology"},{"key":"ref-1545721","author":"NIZP-PZH Zak\u0142ad Epidemiologii Chor\u00f3b Zaka\u017anych i Nadzoru","year":"2018","unstructured":"NIZP-PZH Zak\u0142ad Epidemiologii Chor\u00f3b Zaka\u017anych i Nadzoru (2018): Vaccinations in Poland in 2017."}],"container-title":["Central European Journal of Immunology"],"original-title":[],"link":[{"URL":"https:\/\/ceji.termedia.pl\/pdf-109113-129777","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ceji.termedia.pl\/pdf-109113-129777","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T08:34:10Z","timestamp":1767947650000},"score":1,"resource":{"primary":{"URL":"https:\/\/ceji.termedia.pl\/Molecular-methods-in-diagnostics-of-post-BCG-vaccine-adverse-events,109113,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,27]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"alternative-id":["109113"],"URL":"https:\/\/doi.org\/10.5114\/ceji.2020.97900","relation":{},"ISSN":["1426-3912","1644-4124"],"issn-type":[{"value":"1426-3912","type":"print"},{"value":"1644-4124","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,27]]}}}